Free Trial

IN8bio (INAB) Short Interest Ratio & Short Volume

IN8bio logo
$0.32 0.00 (0.00%)
(As of 11/20/2024 ET)

IN8bio Short Interest Data

IN8bio (INAB) has a short interest of 1.00 million shares, representing 3.12% of the float (the number of shares available for trading by the public). This marks a 578.43% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.9, indicating that it would take 0.9 days of the average trading volume of 543,844 shares to cover all short positions.

Current Short Interest
1,000,000 shares
Previous Short Interest
147,400 shares
Change Vs. Previous Month
+578.43%
Dollar Volume Sold Short
$280,200.00
Short Interest Ratio
0.9 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
46,787,000 shares
Float Size
32,040,000 shares
Short Percent of Float
3.12%
Today's Trading Volume
122,803 shares
Average Trading Volume
543,844 shares
Today's Volume Vs. Average
23%
Short Selling IN8bio?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for IN8bio and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

INAB Short Interest Over Time

INAB Days to Cover Over Time

INAB Percentage of Float Shorted Over Time

IN8bio Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/20241,000,000 shares $280,200.00 +578.4%3.1%0.9 $0.28
10/15/2024147,400 shares $34,491.60 -16.5%0.5%0.2 $0.23
9/30/2024176,500 shares $47,655.00 -6.6%0.5%0.7 $0.27
9/15/2024188,900 shares $59,786.85 -4.5%0.6%0.8 $0.32
8/31/2024197,800 shares $104,121.92 -28.9%0.6%0.5 $0.53
8/15/2024278,200 shares $167,726.78 +13.6%0.9%0.7 $0.60
7/31/2024244,900 shares $205,691.51 -46.5%0.8%0.7 $0.84
7/15/2024457,800 shares $388,672.20 -39.5%1.5%1.2 $0.85
6/30/2024756,900 shares $640,715.85 +94.2%2.5%1.4 $0.85
6/15/2024389,700 shares $424,773.00 +489.6%1.3%0.7 $1.09
5/31/202466,100 shares $78,659.00 -37.4%0.2%0.2 $1.19
5/15/2024105,500 shares $119,215.00 -41.4%0.4%0.3 $1.13
4/30/2024179,900 shares $183,498.00 -64.9%0.6%0.5 $1.02
4/15/2024512,000 shares $522,240.00 +892.3%1.8%1.5 $1.02
3/31/202451,600 shares $60,888.00 -39.2%0.2%0.3 $1.18
3/15/202484,800 shares $96,672.00 +296.3%0.3%0.5 $1.14
2/29/202421,400 shares $23,754.00 -47.9%0.1%0 $1.11
2/15/202441,100 shares $45,210.00 -68.1%0.1%0.1 $1.10
1/31/2024129,000 shares $167,700.00 +49.1%0.5%0.2 $1.30
1/15/202486,500 shares $131,480.00 -25.5%0.4%0.1 $1.52
12/31/2023116,100 shares $160,218.00 -77.9%0.7%0.2 $1.38
12/15/2023525,200 shares $1.00 million +490.1%2.9%0.9 $1.91
11/30/202389,000 shares $73,870.00 +222.5%0.4%0.6 $0.83
11/15/202327,600 shares $25,930.20 -51.0%0.1%0.3 $0.94
10/31/202356,300 shares $55,168.37 -0.2%0.3%0.7 $0.98
10/15/202356,400 shares $52,722.72 -43.1%0.3%0.5 $0.93
9/30/202399,100 shares $103,064.00 +166.4%0.5%0.8 $1.04
9/15/202337,200 shares $34,224.00 -57.4%0.2%0.3 $0.92
8/31/202387,300 shares $91,665.00 +90.2%0.4%0.5 $1.05
8/15/202345,900 shares $54,621.00 +81.4%0.2%0.2 $1.19
7/31/202325,300 shares $29,854.00 -70.1%0.1%0.1 $1.18
7/15/202384,700 shares $137,214.00 +22.2%0.6%0 $1.62
6/30/202369,300 shares $106,722.00 -21.9%0.5%0 $1.54
6/15/202388,700 shares $188,044.00 +14.8%0.6%0 $2.12
5/31/202377,300 shares $234,992.00 -43.8%0.6%0 $3.04
5/15/2023137,500 shares $338,250.00 -88.5%1.1%0 $2.46
4/30/20231,190,000 shares $1.74 million +720.7%13.5%0.3 $1.46
4/15/2023145,000 shares $175,450.00 -3.0%1.7%0.1 $1.21
3/31/2023149,500 shares $194,350.00 -9.4%1.7%1.9 $1.30
3/15/2023165,000 shares $219,450.00 -20.6%1.9%1.8 $1.33
JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)

Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.

Get your free guide NOW before it's too late.
2/28/2023207,800 shares $317,934.00 +127.4%2.4%2.2 $1.53
2/15/202391,400 shares $182,800.00 -13.7%1.1%1 $2.00
1/31/2023105,900 shares $243,146.40 -10.3%1.2%1.7 $2.30
1/15/2023118,000 shares $272,580.00 -10.4%1.4%1.9 $2.31
12/30/2022131,700 shares $304,227.00 +28.5%1.5%2 $2.31
12/15/2022102,500 shares $187,575.00 +45.8%1.2%1.7 $1.83
11/30/202270,300 shares $122,322.00 +42.9%0.8%1.1 $1.74
11/15/202249,200 shares $77,736.00 +21.8%0.6%0 $1.58
10/31/202240,400 shares $78,780.00 -9.0%0.5%0 $1.95
10/15/202244,400 shares $89,244.00 -13.3%0.5%0 $2.01
9/30/202251,200 shares $103,424.00 -40.5%0.6%0 $2.02
9/15/202286,100 shares $237,636.00 +154.7%1.0%0.1 $2.76
8/31/202233,800 shares $87,542.00 -17.2%0.8%0 $2.59
8/15/202240,800 shares $77,112.00 +206.8%0.9%0.7 $1.89
7/31/202213,300 shares $33,782.00 +44.6%0.1%1.1 $2.54
7/15/20229,200 shares $19,964.00 -8.9%0.1%0.7 $2.17
6/30/202210,100 shares $22,826.00 -24.6%0.1%0.6 $2.26
6/15/202213,400 shares $28,542.00 -21.2%0.1%0.5 $2.13
5/31/202217,000 shares $37,571.70 +28.8%0.1%0.5 $2.21
5/15/202213,200 shares $36,696.00 +2.3%0.1%0.3 $2.78
4/30/202212,900 shares $30,960.00 -45.6%0.1%0.3 $2.40
4/15/202223,700 shares $82,476.00 +68.1%0.2%0.5 $3.48
3/31/202214,100 shares $46,953.00 +18.5%0.1%0.3 $3.33
3/15/202211,900 shares $35,700.00 -55.4%0.1%0.3 $3.00
2/28/202226,700 shares $112,140.00 -62.3%0.2%0.8 $4.20
2/15/202270,900 shares $303,452.00 +6.5%0.6%2 $4.28
1/31/202266,600 shares $224,442.00 +17.3%0.5%1.8 $3.37
1/15/202256,800 shares $230,040.00 +108.8%N/A1.9 $4.05
12/31/202127,200 shares $119,408.00 No Change0.2%0.9 $4.39

INAB Short Interest - Frequently Asked Questions

What is IN8bio's current short interest?

Short interest is the volume of IN8bio shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 1,000,000 shares of INAB short. 3.12% of IN8bio's shares are currently sold short. Learn More on IN8bio's current short interest.

What is a good short interest ratio for IN8bio?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. INAB shares currently have a short interest ratio of 1.0. Learn More on IN8bio's short interest ratio.

What is a good short interest percentage for IN8bio?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.12% of IN8bio's floating shares are currently sold short.

Is IN8bio's short interest increasing or decreasing?

IN8bio saw a increase in short interest in October. As of October 31st, there was short interest totaling 1,000,000 shares, an increase of 578.4% from the previous total of 147,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is IN8bio's float size?

IN8bio currently has issued a total of 46,787,000 shares. Some of IN8bio's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. IN8bio currently has a public float of 32,040,000 shares.

How does IN8bio's short interest compare to its competitors?

3.12% of IN8bio's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to IN8bio: Enlivex Therapeutics Ltd. (0.75%), HCW Biologics Inc. (0.04%), LAVA Therapeutics (0.13%), Aileron Therapeutics, Inc. (1.19%), CervoMed Inc. (27.66%), X4 Pharmaceuticals, Inc. (6.70%), Connect Biopharma Holdings Limited (0.06%), Mural Oncology plc (2.62%), Theratechnologies Inc. (0.23%), Entera Bio Ltd. (0.12%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short IN8bio stock?

Short selling INAB is an investing strategy that aims to generate trading profit from IN8bio as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against IN8bio?

A short squeeze for IN8bio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INAB, which in turn drives the price of the stock up even further.

How often is IN8bio's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INAB, twice per month. The most recent reporting period available is October, 31 2024.




This page (NASDAQ:INAB) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners